Epstein Secrets

pproximately 50% higher than had been postulated led to a shorter required duration of follow-up to accrue the prespecified number of events." Dr. Sabatine emphasized the importance of aggressive LDL-lowering treatment in the future. "We need to treat LDL cholesterol more aggressively, and now we have a

hould discuss their LDL cholesterol with their physician and consider whether they need to lower it further." Reference Sabatine MS. Giugliano RP, Keech AC, et al. N Engl J Med. 2017;doi:NEJMoa1615664 http://www.nejm.orq/doUpdf/10.1056/NEJMoa 1615664 Sabatine M. Primary Results of the Further Cardiovas

pproximately 50% higher than had been postulated led to a shorter required duration of follow-up to accrue the prespecified number of events." Dr. Sabatine emphasized the importance of aggressive LDL-lowering treatment in the future. "We need to treat LDL cholesterol more aggressively, and now we have a

hould discuss their LDL cholesterol with their physician and consider whether they need to lower it further." Reference Sabatine MS, Giugliano RP, Keech AC, et al. N Eng! J Med. 2017;doi:NEJMoa1615664 http://www.nejm.orgidoi/pdf/10.1056/NEJMoa1615664 Sabatine M. Primary Results of the Further Cardiovas

approximately 50% higher than had been postulated led to a shorter required duration of follow-up to accrue the prespecified number of events' Dr. Sabatine emphasized the importance of aggressive LDL-lowering treatment in the future. "We need to treat LDL cholesterol more aggressively, and now we have a

hould discuss their LDL cholesterol with their physician and consider whether they need to lower it further." Reference Sabatine MS, Giugliano RP, Keech AC, et al. N Eng! J Med. 2017;doi:NEJMoa1615664 http://www.ne m.orgidoi/pdftl0.1056/NEJMoa1615664 Sabatine M. Primary Results of the Further Cardiovas